PT  - JOURNAL ARTICLE
AU  - Xie, Feng
AU  - Cao, Peng
AU  - Tang, Hai-bo
AU  - Luo, Zhi
AU  - Zhu, Shai-hong
AU  - Zhu, Li-yong
TI  - Hypertension mediated the effects of pericardial adipose tissue on cardiovascular diseases
AID  - 10.1101/2024.01.02.24300740
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.01.02.24300740
4099  - http://medrxiv.org/content/early/2024/01/04/2024.01.02.24300740.short
4100  - http://medrxiv.org/content/early/2024/01/04/2024.01.02.24300740.full
AB  - Background Although previous studies have presented a relevance between pericardial adipose tissue (PAT) and cardiovascular diseases (CVDs), the precise role of PAT in CVDs remains uncertain.Methods In the Mendelian randomization (MR) research, we extracted instrumental variants significantly correlated with PAT to assess its effects on CVDs. Inverse-variance weighted model was elected as the leading MR analytical method. F-statistic was utilized to assess the intensity of instrumental variants and avert weak-tool bias. Numerous sensitivity analyses were adopted to confirm the credibility of outcomes. The mediated effect of hypertension between PAT and CVDs was estimated in 2-step MR analysis.Results The MR research demonstrated genetically determined PAT was remarkably correlated with greater risks of cardiovascular disease (OR 1.15; 95% CI 1.09--1.22, P=1.32*10-6), heart failure (OR 2.62; 95% CI 1.28--5.34, P=0.008), coronary heart disease (OR 3.53; 95% CI 1.55--8.06, P=0.003), ischemic heart disease (OR 2.31; 95% CI 1.14--4.67, P=0.020), ischemic stroke (OR 3.18; 95% CI 1.63--6.20, P=0.001), and venous thromboembolism (OR 1.02; 95% CI 1.00--1.04, P=0.015). And the correlation was partially mediated by hypertension. Results were verified by sensitivity analysis.Conclusions Genetic determined PAT was remarkably correlated with additional risks of diverse CVDs. Identified as a mediator, hypertension had a significant influence on the causal association. The correlation between PAT and CVDs deserves further exploration.What Is New?This was the first Mendelian randomization research to detect the potential causal relationship of genetically determined PTA on multiple CVDs risks and confirm the mediating effect of hypertension on the causal association.What Is Relevant?The MR research not only estimated the causal effect of PAT on hypertension but also identified the mediating role of hypertension between PAT and CVDs.Clinical/Pathophysiological Implications?This study revealed PAT promoted CVDs progression and hypertension played an intermediary role, which indicated that PAT might serve as a potential therapeutic target and antihypertensive drugs could be conjunctly used to provide cardiovascular benefits.especially for people with obesity, because they had more PAT accumulation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was sponsored by the General Program of National Natural Science Foundation of China (grant NO.82370676) and Key Research and Development Program of Hunan province (grant NO. 2022SK2001).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research was based on genome-wide association studies and ethical approval of all contributors had been obtained.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data of this research are available.Nonstandard Abbreviations and AcronymsAAaortic aneurysmAFatrial fibrillationCAcardiac arrhythmiasCADcoronary artery diseaseCEScardioembolic strokeCHDcoronary heart diseaseCIconfidence intervalCVDcardiovascular diseaseCVDscardiovascular diseasesGWASgenome-wide association studyHCMhypertrophic cardiomyopathyHFheart failureIHDischemic heart diseaseISischemic strokeIVsinstrumental variablesIVWinverse-variance weightingLASlarge artery strokeLDlinkage disequilibriumMImyocardial infarctionMRmendelian randomizationORodds ratioPATpericardial adipose tissueSAHsubarachnoid hemorrhageSNPssingle-nucleotide polymorphismSVSsmall vessel strokeVTEvenous thromboembolism.